Detection of recurrence after surgery for colorectal cancer.

Of all patients operated for colorectal cancer, 1 in 3 will suffer from cancer recurrence, and most of these patients will die from disseminated disease. Postoperative follow-up aims at improving these grim figures. This sound idea has not been supported by any empirical data. In the current article, we discuss some theoretical issues concerning colorectal cancer follow-up, and present results of a cost-effectiveness analysis, used to model the natural history of colorectal cancer recurrence and the costs and effects of follow-up and re-operation. The expected results of three policies were calculated: no follow-up, selective follow-up and intensive follow-up. For most patients, follow-up will only lead to a significant increase in costs, without increase in (quality-adjusted) life expectancy. Colorectal cancer follow-up is not "evidence-based medicine".

[1]  S. Granqvist,et al.  Postoperative follow-up of patients with colorectal carcinoma by colonoscopy. , 1992, The European journal of surgery = Acta chirurgica.

[2]  A. Altendorf-Hofmann,et al.  Factors influencing the natural history of colorectal liver metastases , 1994, The Lancet.

[3]  G. Steele,et al.  Standard postoperative monitoring of patients after primary resection of colon and rectum cancer , 1993, Cancer.

[4]  N. McC. Mortensen,et al.  Endoluminal ultrasonography in the follow‐up of patients with rectal cancer , 1994, The British journal of surgery.

[5]  G Steele,et al.  Follow-up plans after treatment of primary colon and rectum cancer , 1991, World journal of surgery.

[6]  A. Stiggelbout,et al.  Follow‐Up of Patients with Colorectal Cancer A Meta‐Analysis , 1994, Annals of surgery.

[7]  G. Ballantyne,et al.  Surgical treatment of liver metastases in patients with colorectal cancer , 1993, Cancer.

[8]  H. Wanebo,et al.  Results of surgical treatment of nonhepatic recurrence of colorectal carcinoma , 1993, Cancer.

[9]  R. Doci,et al.  Comparing surgical resection of limited hepatic metastases from colorectal cancer to non-operative treatment. , 1993, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  A. Vernava,et al.  Current follow-up strategies after resection of colon cancer , 1994, Diseases of the colon and rectum.

[11]  P. gordon,et al.  Contemporary operative management of pulmonary metastases of colorectal origin , 1988, Diseases of the colon and rectum.

[12]  R. Tsuchiya,et al.  Surgical resection of pulmonary metastases from colorectal cancer. 10‐year follow‐up , 1989, Cancer.

[13]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[14]  J. Kievit,et al.  Utility and cost of carcinoemhryonic antigen monitoring in colon cancer follow‐up evaluation: A markove analysis , 1990, Cancer.

[15]  J. Habbema,et al.  Attitudes Towards Detection and Management of Hepatic Metastases of Colorectal Origin: A Second Look , 1994, HPB surgery : a world journal of hepatic, pancreatic and biliary surgery.

[16]  J. Houghton,et al.  CEA to detect recurrence of colon cancer. , 1994, JAMA.

[17]  A. Zinsmeister,et al.  Pulmonary resection of metastatic colorectal adenocarcinoma. A ten year experience. , 1986, Chest.

[18]  Shields Tw,et al.  The incidence of solitary pulmonary metastasis from carcinoma of the large intestine. , 1976 .

[19]  S. Miyoshi,et al.  [Surgical resection of pulmonary metastases from colorectal cancer]. , 1993, Kyobu geka. The Japanese journal of thoracic surgery.

[20]  F. Safi,et al.  Is follow-up of colorectal cancer patients worthwhile? , 1993, Diseases of the colon and rectum.